1. Home
  2. OBAI vs CYCN Comparison

OBAI vs CYCN Comparison

Compare OBAI & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG-17 Inc. Common Stock

OBAI

TG-17 Inc. Common Stock

N/A

Current Price

$0.50

Market Cap

15.2M

ML Signal

N/A

Logo Cyclerion Therapeutics Inc.

CYCN

Cyclerion Therapeutics Inc.

HOLD

Current Price

$3.50

Market Cap

16.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBAI
CYCN
Founded
2017
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2M
16.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OBAI
CYCN
Price
$0.50
$3.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
709.0K
19.0K
Earning Date
05-27-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$1.03
52 Week High
$19.95
$8.48

Technical Indicators

Market Signals
Indicator
OBAI
CYCN
Relative Strength Index (RSI) 37.81 53.77
Support Level $0.45 $2.93
Resistance Level $0.65 $3.97
Average True Range (ATR) 0.05 0.23
MACD -0.02 -0.04
Stochastic Oscillator 15.78 34.17

Price Performance

Historical Comparison
OBAI
CYCN

About OBAI TG-17 Inc. Common Stock

Our Bond Inc is a personal security service through its AI-powered Preventive Personal Security platform. It is trusted by corporations, cities, and universities, and has already supported many security service requests, emergencies and life-saving interventions. The cloud-based Bond Preventative Personal Security Platform provides users with remote protective services via phone app (using its Bond Preventative Personal Security Platform) and with 24/7 support from its Personal Security Agents, who are in Bond Command Centers and can respond rapidly. It offers distinct services through its phone app (the Bond App) and fully automated Bond Command Centers. Geographically, the company operates in Israel, France, and United States. It derives maximum revenue from United States.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: